Literature DB >> 21571947

Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver.

Beshay N M Zordoky1, Anwar Anwar-Mohamed, Mona E Aboutabl, Ayman O S El-Kadi.   

Abstract

The use of doxorubicin (DOX) is limited by significant cardiotoxicity, nephrotoxicity, and hepatotoxicity. We have previously shown that DOX cardiotoxicity induces several cardiac cytochrome P450 (P450) enzymes with subsequent alteration in P450-mediated arachidonic acid metabolism. Therefore, in the current study, we investigated the effect of acute DOX toxicity on P450 expression and arachidonic acid metabolism in the kidney and liver of male Sprague-Dawley rats. Acute DOX toxicity was induced by a single intraperitoneal injection (15 mg/kg) of the drug. After 6 and 24 h, the kidneys and livers were harvested, and several P450 gene and protein expressions were determined by real-time polymerase chain reaction and Western blot analyses, respectively. Kidney and liver microsomal protein from control or DOX-treated rats was incubated with arachidonic acid, and its metabolites were determined by liquid chromatography-electron spray ionization-mass spectrometry. Our results showed that acute DOX toxicity caused an induction of CYP1B1 and CYP4A enzymes and an inhibition of CYP2B1 and CYP2C11 in both the kidney and liver. CYP2E1 was induced and soluble epoxide hydrolase (sEH) was inhibited in the kidney only. In addition, DOX toxicity caused a significant increase in epoxyeicosatrienoic acids formation in the kidney and a significant increase in 20-hydroxyeicosatetraenoic acid formation in both the kidney and the liver. In conclusion, acute DOX toxicity alters the expression of several P450 and sEH enzymes in an organ-specific manner. These changes can be attributed to DOX-induced inflammation and resulted in altered P450-mediated arachidonic acid metabolism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21571947     DOI: 10.1124/dmd.111.039123

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  20 in total

1.  Screening and validation for plasma biomarkers of nephrotoxicity based on metabolomics in male rats.

Authors:  Yubo Li; Haoyue Deng; Liang Ju; Xiuxiu Zhang; Zhenzhu Zhang; Zhen Yang; Lei Wang; Zhiguo Hou; Yanjun Zhang
Journal:  Toxicol Res (Camb)       Date:  2015-11-05       Impact factor: 3.524

2.  Arachidonic Acid Metabolism by Human Cardiovascular CYP2J2 Is Modulated by Doxorubicin.

Authors:  William R Arnold; Javier L Baylon; Emad Tajkhorshid; Aditi Das
Journal:  Biochemistry       Date:  2017-12-12       Impact factor: 3.162

3.  Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic Machineries.

Authors:  Sara Emad El-Agamy; Amal Kamal Abdel-Aziz; Sara Wahdan; Ahmed Esmat; Samar S Azab
Journal:  Mol Neurobiol       Date:  2017-10-16       Impact factor: 5.590

4.  Anthracycline derivatives inhibit cardiac CYP2J2.

Authors:  Justin S Kim; Andres S Arango; Swapnil Shah; William R Arnold; Emad Tajkhorshid; Aditi Das
Journal:  J Inorg Biochem       Date:  2022-01-13       Impact factor: 4.155

5.  Magnesium isoglycyrrhizinate ameliorates doxorubicin-induced acute cardiac and hepatic toxicity via anti-oxidant and anti-apoptotic mechanisms in mice.

Authors:  Zhonglin Wu; Yuanyuan Zhang; Tao Song; Qiongtao Song; Ying Zhang; Xuan Zhang; Xue Han; Jianping Zhang; Li Chu
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.447

Review 6.  Soluble epoxide hydrolase: gene structure, expression and deletion.

Authors:  Todd R Harris; Bruce D Hammock
Journal:  Gene       Date:  2013-05-20       Impact factor: 3.688

7.  Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.

Authors:  Hassan N Althurwi; Mandy M Y Tse; Ghada Abdelhamid; Beshay N M Zordoky; Bruce D Hammock; Ayman O S El-Kadi
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

8.  Role of inflammatory, oxidative, and ER stress signaling in the neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats.

Authors:  Noha M Mounier; Sara A Wahdan; Amany M Gad; Samar S Azab
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-03-23       Impact factor: 3.000

9.  Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profiling.

Authors:  W B Mattes; H G Kamp; E Fabian; M Herold; G Krennrich; R Looser; W Mellert; A Prokoudine; V Strauss; B van Ravenzwaay; T Walk; H Naraoka; K Omura; I Schuppe-Koistinen; S Nadanaciva; E D Bush; N Moeller; P Ruiz-Noppinger; S P Piccoli
Journal:  Biomed Res Int       Date:  2013-05-21       Impact factor: 3.411

10.  Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53/Bcl-xl.

Authors:  Guanyu Wang; Jiawei Zhang; Luying Liu; Sherven Sharma; Qinghua Dong
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.